Olanzapine use in women with antipsychotic-induced hyperprolactinemia

Am J Psychiatry. 1998 Oct;155(10):1458. doi: 10.1176/ajp.155.10.1458.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Amenorrhea / chemically induced
  • Amenorrhea / drug therapy
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines
  • Female
  • Galactorrhea / chemically induced
  • Galactorrhea / drug therapy
  • Humans
  • Hyperprolactinemia / chemically induced*
  • Hyperprolactinemia / drug therapy*
  • Middle Aged
  • Olanzapine
  • Perphenazine / adverse effects
  • Perphenazine / therapeutic use
  • Pirenzepine / analogs & derivatives*
  • Pirenzepine / therapeutic use
  • Risperidone / adverse effects
  • Risperidone / therapeutic use
  • Schizophrenia / drug therapy

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Pirenzepine
  • Perphenazine
  • Risperidone
  • Olanzapine